Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation

被引:439
|
作者
Sato, S
Ward, CL
Krouse, ME
Wine, JJ
Kopito, RR
机构
[1] STANFORD UNIV,DEPT BIOL SCI,STANFORD,CA 94305
[2] STANFORD UNIV,DEPT PSYCHOL,CYST FIBROSIS RES LAB,STANFORD,CA 94305
关键词
D O I
10.1074/jbc.271.2.635
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The common Delta F508 mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) interferes with the biosynthetic folding of nascent CFTR polypeptides, leading to their retention and rapid degradation in an intracellular compartment proximal to the Gels apparatus, Neither the pathway by which wild-type CFTR folds nor the mechanism by which the Phe(508) deletion interferes with this process is well understood, We have investigated the effect of glycerol, a polyhydric alcohol known to stabilize protein conformation, on the folding of CFTR and Delta F508 in vivo. Incubation of transient and stable Delta F508 tranfectants with 10% glycerol induced a significant accumulation of Delta F508 protein bearing complex N-linked oligosaccharides, indicative of their transit to a compartment distal to the endoplasmic reticulum (ER). This accumulation was accompanied by an increase in mean whole cell cAMP activated chloride conductance, suggesting that the glycerol-rescued Delta F508 polypeptides form functional plasma membrane CFTR channels, These effects were dose- and time-dependent and fully reversible, Glycerol treatment also stabilized immature (core-glycosylated) Delta F508 and CFTR molecules that are normally degraded rapidly. These effects of glycerol were not due to a general disruption of ER quality control processes but appeared to correlate with the degree of temperature sensitivity of specific CFTR mutations, These data suggest a model in which glycerol serves to stabilize an otherwise unstable intermediate in CFTR biosynthesis, maintaining it in a conformation that is competent for folding and subsequent release from the ER quality control apparatus.
引用
收藏
页码:635 / 638
页数:4
相关论文
共 50 条
  • [1] Glycerol reverses the misfolding phenotype of the misfolding phenotype of the most common cystic fibrosis mutation.
    Sato, S
    Ward, CL
    Krouse, ME
    Wine, JJ
    Kopito, RR
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1996, 7 : 1534 - 1534
  • [2] THE RELATION BETWEEN GENOTYPE AND PHENOTYPE IN CYSTIC-FIBROSIS - ANALYSIS OF THE MOST COMMON MUTATION (DELTA-F508)
    KEREM, E
    COREY, M
    KEREM, BS
    ROMMENS, J
    MARKIEWICZ, D
    LEVISON, H
    TSUI, LC
    DURIE, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (22): : 1517 - 1522
  • [3] Mechanistic Approaches to Improve Correction of the Most Common Disease-Causing Mutation in Cystic Fibrosis
    Bali, Vedrana
    Lazrak, Ahmed
    Guroji, Purushotham
    Matalon, Sadis
    Bebok, Zsuzsanna
    [J]. PLOS ONE, 2016, 11 (05):
  • [4] Pyrosequencing™ assess the most common cystic fibrosis mutations
    Schiller, A
    Dunker, J
    Larsson, U
    Storgärds, M
    Alderborn, A
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 137 - 137
  • [5] smFRET Reveals Structural Basis for Conformational Misfolding of a Cystic Fibrosis Mutation in CFTR
    Krainer, Georg
    Treff, Antoine
    Hartmann, Andreas
    Chang, Henry
    Stone, Tracy
    Rath, Ariana
    Deber, Charles
    Schlierf, Michael
    [J]. BIOPHYSICAL JOURNAL, 2017, 112 (03) : 204A - 204A
  • [6] Is delta-F508 the most common mutation in cystic fibrosis transmembrane regulator gene among southwestern Iranian patients with cystic fibrosis?
    Farjadian, S.
    Moghtaderi, M.
    Kashef, S.
    Aleyasin, S.
    Najib, K.
    [J]. ALLERGY, 2012, 67 : 544 - 544
  • [7] In vitro assessment of triple combination therapy for the most common disease-associated mutation in cystic fibrosis
    Yeh, Han-, I
    Hwang, Tzyh-Chang
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 59 (02)
  • [8] THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR - EFFECTS OF THE MOST COMMON CYSTIC FIBROSIS-CAUSING MUTATION ON THE SECONDARY STRUCTURE AND STABILITY OF A SYNTHETIC PEPTIDE
    THOMAS, PJ
    SHENBAGAMURTHI, P
    SONDEK, J
    HULLIHEN, JM
    PEDERSEN, PL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (09) : 5727 - 5730
  • [9] Most Common Causes of Gastrointestinal Hospitalization in Patients With Cystic Fibrosis
    Caplan, Claire
    Wikholm, Colin
    Ahmad, Akram I.
    Pothoulakis, Ioannis
    Bhogal, Loveleen
    Sehgal, Abhinav
    Cho, Jang
    Schumacher, Sarah
    Zhang, Jennie
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S82 - S83
  • [10] Pyrosequencing™ assess the most common Cystic Fibrosis mutations.
    Toth, SI
    Schiller, AL
    Dunker, J
    Larsson, U
    Storgards, M
    Alderborn, A
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 407 - 407